Blog

AstraZeneca Pharma gains CDSCO approval to import cancer drug Lynparza

November 26, 2024
No Comments

Share it

AstraZeneca Pharma India has received approval from the CDSCO for Olaparib film-coated tablets, set to launch in India for treating advanced endometrial cancer.

Leave a Comment Cancel Reply

Arvind Fashions Q3 Results: Shares jump on strong profit growth, margins improve

February 5, 2025

Dividend Stock: Page Industries takes FY25 payouts to ₹700 per share so far

February 5, 2025

Zydus Lifesciences Q3 Results: US formulation sales near $300 million, forex gains aid profit

February 5, 2025

Symphony Q3 Results: Stock tanks after exceptional item drags company to a net loss; margin narrows

February 5, 2025

Blog

AstraZeneca Pharma gains CDSCO approval to import cancer drug Lynparza

Leave a Comment Cancel Reply

Related Article

Open an Account in less than 1 Min.

Services

Company

Get in touch